03/13/2025
5:06 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/12/2025
4:23 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2025
6:38 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
4:54 PM | McFarlane Neil F. (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
4:55 PM | Clifton R. LaDuane (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
4:55 PM | Schafer Joshua (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
4:57 PM | Sangiovanni Timothy J. (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
3:38 PM | McFarlane Neil F. (Reporting)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2025
8:32 AM | Adage Capital Management, L.P. (Filed by)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/10/2025
4:37 PM | McFarlane Neil F. (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
12:23 PM | BlackRock, Inc. (Filed by)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
Get the Latest News and Ratings for ZVRA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Zevra Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
02/03/2025
4:19 PM | McFarlane Neil F. (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
4:20 PM | Clifton R. LaDuane (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
4:22 PM | Schafer Joshua (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
4:23 PM | Thompson Rahsaan (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
4:24 PM | Sangiovanni Timothy J. (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
4:28 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:53 PM | Nantahala Capital Management, LLC (Filed by)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
11/04/2024
1:15 PM | VANGUARD GROUP INC (Filed by)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
| Form SC 13G/A | |
10/16/2024
3:46 PM | Watton Corey Michael (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
3:17 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
3:54 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 424B5 | |
07/17/2024
4:54 PM | Clifton R. LaDuane (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
3:39 PM | Anderson Thomas (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2024
3:37 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2024
3:23 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 424B2
Transaction specifc information for a delayed shelf offering | |
07/09/2024
8:23 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
4:11 PM | Thompson Rahsaan (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/25/2024
4:13 PM | Thompson Rahsaan (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
11:15 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form EFFECT | |
05/15/2024
8:15 PM | Watton Corey Michael (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
8:18 PM | Calder Douglas W (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
8:20 PM | FAVORITO TAMARA A (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
8:28 PM | DIXON WENDY L (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
8:31 PM | Bode John B (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
8:05 PM | Anderson Thomas (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
8:13 PM | Shih Alvin (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
6:54 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
6:49 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form DEFA14A | |
04/10/2024
3:23 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 424B3 | |
04/10/2024
6:46 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Ex CIA predicts 40% “double crash” – April 11 (Ad) The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology…
They’re studying something far more alien…
Something you’ve never seen before… Click here for my latest prediction before it’s taken offline. |
04/08/2024
11:15 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form EFFECT | |
04/05/2024
6:39 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form S-3/A | |
04/01/2024
4:27 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2024
7:28 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
